femMED Menopause Relief
Natural health product licensed in Canada
If this product were sold in France
- Conditions légales
Leonurus cardiaca L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les femmes enceintes
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cimicifuga racemosa Source : Racine | 40 mg | Not calculated |
| Leonurus cardiaca Source : Feuille | 50 mg | Not calculated |
| Mitchella repens Source : Feuille | 75 mg | Not calculated |
| Punica granatum Source : Seed extract Extraction ratio : 4:1 Dry plant equivalent : 300 mg | 75 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Stéarate de magnésium, Eau, Cellulose, microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
This product is specially formulated to help alleviate the symptoms associated with menopause including hot flashes, night sweats, mood swings, sleep disturbances and irritability.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- femMED Canada, Inc.
- NPN or DIN-HM
- 80025767
- Status
- Active licence
- Licence date
- 15 June 2011
- Revision date
- 22 April 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80025767
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Punica granatum
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “femMED Menopause Relief”, https://compoatlas.com/en/supplements/canada/80025767-femmed-menopause-relief, updated 22 April 2021.